Tian'an Pharmaceutical Co Ltd
Tian'an Pharmaceutical Co., Ltd. develops, manufactures, and sells traditional Chinese herbal medicines, including pallets, hard capsules, and soft ointments for the treatment and prevention of diseases in China. It also engages in the research and development of biology goods and health care products. The company's pharmaceutical and nutraceutical products include Compound Ginseng capsule, a Chi… Read more
Tian'an Pharmaceutical Co Ltd (TNPH) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: 0.023x
Based on the latest financial reports, Tian'an Pharmaceutical Co Ltd (TNPH) has a cash flow conversion efficiency ratio of 0.023x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.97K) by net assets ($-85.65K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Tian'an Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2004–2024)
This chart illustrates how Tian'an Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Tian'an Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tian'an Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CORONATION INSURANCE PLC
XNSA:WAPIC
|
N/A |
|
RAINBOW TOURISM GROUP LIMITED
XZIM:RTG
|
N/A |
|
Inspirit Energy Holdings Plc
LSE:INSP
|
-0.936x |
|
Tigere Real Estate Investment Trust
XZIM:TIG
|
N/A |
|
NUMERAL LTD - (USD)
SEM:GOLI
|
N/A |
|
Solartron PCL
STU:TUU
|
0.004x |
|
ICFG Limited
LSE:ICFG
|
N/A |
|
IDEA FABRIK
BE:TI4
|
N/A |
Annual Cash Flow Conversion Efficiency for Tian'an Pharmaceutical Co Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Tian'an Pharmaceutical Co Ltd from 2004 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-85.65K | $-3.18K | 0.037x | -81.37% |
| 2023-12-31 | $-65.41K | $-13.02K | 0.199x | +185.20% |
| 2022-12-31 | $-201.07K | $-14.04K | 0.070x | -66.47% |
| 2021-12-31 | $-125.91K | $-26.22K | 0.208x | -60.53% |
| 2020-12-31 | $-149.23K | $-78.72K | 0.528x | -31.26% |
| 2019-12-31 | $-114.15K | $-87.59K | 0.767x | -22.93% |
| 2018-12-31 | $18.27K | $18.20K | 0.996x | +464.77% |
| 2007-12-31 | $14.53 Million | $2.56 Million | 0.176x | +26.66% |
| 2006-12-31 | $10.50 Million | $1.46 Million | 0.139x | -31.82% |
| 2005-12-31 | $8.53 Million | $1.74 Million | 0.204x | +158.78% |
| 2004-12-31 | $5.52 Million | $-1.92 Million | -0.347x | -- |